Authors: Girardi, E Arici, C Ferrara, M Ripamonti, D Aloisi, MS Alessandrini, A Scalzini, A Monforte, AD Serraino, D Ippolito, G

Citation: E. Girardi et al., Estimating duration of HIV infection with CD4 cell count and HIV-1 RNA at presentation, AIDS, 15(16), 2001, pp. 2201-2203

Authors: Perno, CF Cozzi-Lepri, A Balotta, C Forbici, F Violin, M Bertoli, A Facchi, G Pezzotti, P Cadeo, G Tositti, G Pasquinucci, S Pauluzzi, S Scalzini, A Salassa, B Vincenti, A Phillips, AN Dianzani, F Appice, A Angarano, G Monno, L Ippolito, G Moroni, M Monforte, AD

Citation: Cf. Perno et al., Secondary mutations in the protease region of human immunodeficiency virusand virologic failure in drug-naive patients treated with protease inhibitor-based therapy, J INFEC DIS, 184(8), 2001, pp. 983-991

Authors: Floridia, M Bucciardini, R Ricciardulli, D Fragola, V Pirillo, MF Weimer, LE Tomino, C Giannini, G Galluzzo, CM Andreotti, M Cargnel, A Alberici, F De Rienzo, B Leoncini, F Fiaccadori, F Francisci, D Grillone, W Ortona, T Piazza, S Scalzini, A Nigra, E Tumietto, F Vella, S

Citation: M. Floridia et al., A randomized, double-blind trial on the use of a triple combination including nevirapine, a nonnucleoside reverse transcriptase HIV inhibitor, in antiretroviral-naive patients with advanced disease, J ACQ IMM D, 20(1), 1999, pp. 11-19

Authors: Marabotti, C Chiesa, F Scalzini, A Antonelli, F Lari, R Franchini, C Data, PG

Citation: C. Marabotti et al., Cardiac and humoral changes induced by recreational scuba diving, UNDERS HYP, 26(3), 1999, pp. 151-158

Authors: Matteelli, A Olliaro, P Signorini, L Cadeo, G Scalzini, A Bonazzi, L Caligaris, S Tomasoni, L Tebaldi, A Carosi, G

Citation: A. Matteelli et al., Tolerability of twice-weekly rifabutin-isoniazid combinations versus dailyisoniazid for latent tuberculosis in HIV-infected subjects: a pilot study, INT J TUBE, 3(11), 1999, pp. 1043-1046